A new trading day began on Friday, with Aptose Biosciences Inc (NASDAQ: APTO) stock price down -22.13% from the previous day of trading, before settling in for the closing price of $0.24. APTO’s price has ranged from $0.23 to $2.91 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 76.39%. With a float of $16.19 million, this company’s outstanding shares have now reached $19.52 million.
In an organization with 35 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 52.33%, operating margin of -5123.32%, and the pretax margin is -5066.98%.
Aptose Biosciences Inc (APTO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Aptose Biosciences Inc is 17.07%, while institutional ownership is 16.57%.
Aptose Biosciences Inc (APTO) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.44 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.39% per share during the next fiscal year.
Aptose Biosciences Inc (NASDAQ: APTO) Trading Performance Indicators
Here are Aptose Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.05, a number that is poised to hit -0.35 in the next quarter
Technical Analysis of Aptose Biosciences Inc (APTO)
Let’s dig in a bit further. During the last 5-days, its volume was 2.98 million. That was better than the volume of 0.27 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.02%. Additionally, its Average True Range was 0.04.
During the past 100 days, Aptose Biosciences Inc’s (APTO) raw stochastic average was set at 8.96%, which indicates a significant decrease from 20.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 146.64% in the past 14 days, which was higher than the 89.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3753, while its 200-day Moving Average is $0.8835. However, in the short run, Aptose Biosciences Inc’s stock first resistance to watch stands at $0.2100. Second resistance stands at $0.2300. The third major resistance level sits at $0.2700. If the price goes on to break the first support level at $0.1500, it is likely to go to the next support level at $0.1100. The third support level lies at $0.0900 if the price breaches the second support level.
Aptose Biosciences Inc (NASDAQ: APTO) Key Stats
With a market capitalization of 4.10 million, the company has a total of 18,110K Shares Outstanding. Currently, annual sales are 0 K while annual income is -51,210 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,950 K.
